IL159821A0 - Diazacycloalkanes as oxytocin agonists - Google Patents

Diazacycloalkanes as oxytocin agonists

Info

Publication number
IL159821A0
IL159821A0 IL15982102A IL15982102A IL159821A0 IL 159821 A0 IL159821 A0 IL 159821A0 IL 15982102 A IL15982102 A IL 15982102A IL 15982102 A IL15982102 A IL 15982102A IL 159821 A0 IL159821 A0 IL 159821A0
Authority
IL
Israel
Prior art keywords
diazacycloalkanes
oxytocin agonists
oxytocin
agonists
Prior art date
Application number
IL15982102A
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IL159821A0 publication Critical patent/IL159821A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL15982102A 2001-08-16 2002-08-06 Diazacycloalkanes as oxytocin agonists IL159821A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0120051.8A GB0120051D0 (en) 2001-08-16 2001-08-16 Oxytocin agonists
PCT/GB2002/003593 WO2003016316A1 (en) 2001-08-16 2002-08-06 Diazacycloalkanes as oxytocin agonists

Publications (1)

Publication Number Publication Date
IL159821A0 true IL159821A0 (en) 2004-06-20

Family

ID=9920554

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15982102A IL159821A0 (en) 2001-08-16 2002-08-06 Diazacycloalkanes as oxytocin agonists

Country Status (18)

Country Link
US (1) US20050032777A1 (ru)
EP (1) EP1421087A1 (ru)
JP (1) JP2005501858A (ru)
KR (1) KR20040023728A (ru)
CN (1) CN1285594C (ru)
AR (1) AR042591A1 (ru)
CA (1) CA2453962A1 (ru)
GB (1) GB0120051D0 (ru)
HK (1) HK1071132A1 (ru)
IL (1) IL159821A0 (ru)
MX (1) MXPA04001447A (ru)
NO (1) NO20041819L (ru)
NZ (1) NZ530587A (ru)
PL (1) PL367543A1 (ru)
RU (2) RU2311417C2 (ru)
UY (1) UY27413A1 (ru)
WO (1) WO2003016316A1 (ru)
ZA (1) ZA200400272B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1449844A1 (en) 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
NZ544449A (en) 2003-06-23 2008-10-31 Cv Therapeutics Inc Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
EP1512687A1 (en) * 2003-09-05 2005-03-09 Ferring B.V. Piperazines as oxytocin agonists
EP1632494A1 (en) * 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
JP2009512730A (ja) * 2005-10-24 2009-03-26 ワイス オキシトシン受容体作用薬として有用な三環式化合物
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds
GB201004677D0 (en) 2010-03-19 2010-05-05 Vantia Ltd New salt
CN102905720A (zh) 2010-05-18 2013-01-30 日内瓦大学 催产素样分子的新用途及相关的方法
EP2575853B1 (en) 2010-05-25 2016-08-24 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
WO2018107216A1 (en) * 2016-12-12 2018-06-21 The University Of Sydney Non-peptide oxytocin receptor agonists
CN113429379A (zh) * 2021-06-28 2021-09-24 江苏法安德医药科技有限公司 一种lh-1801中间体及其制备方法和应用
CN116120261B (zh) * 2022-11-30 2024-01-23 浙大宁波理工学院 一种3-[（4-磺胺哌嗪-1-基）甲基]苯甲酸类化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657424B2 (en) * 1992-07-02 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
AR011913A1 (es) * 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
JPH111456A (ja) * 1997-06-13 1999-01-06 Otsuka Pharmaceut Co Ltd アミド誘導体
US5968938A (en) * 1997-06-18 1999-10-19 Merck & Co., Inc. Piperazine oxytocin receptor antagonists
GB2326639A (en) * 1997-06-18 1998-12-30 Merck & Co Inc Piperazine Oxytocin Receptor Antagonists

Also Published As

Publication number Publication date
GB0120051D0 (en) 2001-10-10
RU2311417C2 (ru) 2007-11-27
RU2004101060A (ru) 2005-06-27
EP1421087A1 (en) 2004-05-26
AR042591A1 (es) 2005-06-29
WO2003016316A8 (en) 2003-10-02
WO2003016316A1 (en) 2003-02-27
PL367543A1 (en) 2005-02-21
RU2007121219A (ru) 2008-12-20
CA2453962A1 (en) 2003-02-27
CN1543467A (zh) 2004-11-03
MXPA04001447A (es) 2004-07-08
NO20041819L (no) 2004-05-14
JP2005501858A (ja) 2005-01-20
KR20040023728A (ko) 2004-03-18
HK1071132A1 (en) 2005-07-08
UY27413A1 (es) 2003-02-28
ZA200400272B (en) 2004-11-18
NZ530587A (en) 2004-12-24
US20050032777A1 (en) 2005-02-10
CN1285594C (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
HK1071132A1 (en) Diazycycloalkanes as oxytocin agonists
IL158517A0 (en) Novel 4-anilinoquinoline-3-carboxamides
SI1671949T1 (sl) Substituirani pridinilamini
IL163928A0 (en) Pyridinoylpiperidines as 5-htf agonists
GB0119467D0 (en) Novel compound
HK1034639A2 (en) Holder
EP1387687A4 (en) NEW USE
GB0100762D0 (en) Novel use
GB0115181D0 (en) Novel use
PL362643A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
SI1406858T1 (sl) Substituirani 4-aminocikloheksanoli
GB0104554D0 (en) New uses
EP1384783A4 (en) NEW MAXIZYM
EG23036A (en) Novel pyrrolecarboxamides
HUP0303329A3 (en) New phenylpiperzines
PL364090A1 (en) New benzylaminopyrimidines
PL364601A1 (en) Substituted benzo-nitro-heterocycles
PL364076A1 (en) Novel pyridylmethylaminopyrimidines
GB0108110D0 (en) Keeps
EG23586A (en) Haemagel solution
GB0102601D0 (en) New Uses
GB0119169D0 (en) Novel pyridyl-piperazines
GB0126587D0 (en) Pole table skittles game - latch
HU0100486D0 (en) Bolyhos spirit
PL112160U1 (en) Holder